1Benson WE, Cruickshanks KC, Fong DS, et al. Surgical management of macular holes: a report by the American Academy of Ophthalmology. Ophthalmology, 2001,108: 1328-1335.
2Scott IU, Moraczewski AL, Smiddy WE, et al. Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery. Am J Ophthalmol, 2003,135: 633-640.
3Brooks HL. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology, 2000,107: 1939-1949.
4Boldt HC, Munden PM, Folk JC, et al. Visual field defects after macular hole surgery. Am J Ophthalmol, 1996,122: 371-381.
5Hirata A, Yonemura N, Hasumura T, et al. Effect of infusion air pressure on visual field defects after macular hole surgery. Am J Ophthalmol, 2000,130:611-616.
6Welch JC. Dehydration injury as a possible cause of visual field defect after pars plana vitrectomy for macular hole. Am J Ophthalmol, 1997, 124: 698-699.
7Kanda S,Uemura A, Yamashita T, et al. Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol, 2004, 122: 1447-1451.
8Tsuiki E, Fujikawa A, Miyamura N, et al. Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol, 2007, 143: 704-705.
9Gandorfer A, Haritoglou C, Gass CA, et al. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol, 2001, 132: 431-433.
10Ziemssen F,L u ke M, Messias A,et al. Safety monitoring in bevacizumab (Avastin) treatment:, retinal function assessed by psychophysical (visual fields,colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients [J]. International Ophthalmology,2008; 28: 101-109.
